Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cytomx Thera
(NQ:
CTMX
)
1.210
+0.020 (+1.68%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cytomx Thera
< Previous
1
2
3
4
5
6
Next >
Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge
January 06, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 550 points on Friday.
Via
Benzinga
CytomX Shares Move Higher On Collaborating Pact With This Famed COVID-19 Vaccine Maker
January 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 06, 2023
Via
Benzinga
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket
January 06, 2023
Gainers OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products...
Via
Benzinga
CytomX Shares Jump After Cancer Therapy Pact With Pharma Major Regeneron
November 17, 2022
Via
Benzinga
Recap: CytomX Therapeutics Q2 Earnings
August 04, 2022
CytomX Therapeutics (NASDAQ:CTMX) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:15 PM. Here's what investors need to know about the announcement.
Via
Benzinga
CytomX Therapeutics Cuts Workforce, Extend Cash Runway Into 2025
July 14, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 06, 2023
The final day of trading this week is here and we're starting it off with a look at the biggest pre-market stock movers for Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
January 05, 2023
Via
Benzinga
Why Elevate Credit Shares Are Trading Higher By Over 71%? Here Are 43 Stocks Moving In Thursday's Mid-Day Session
November 17, 2022
Gainers Elevate Credit, Inc. (NYSE: ELVT) shares surged 71.2% to $1.8150 after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67...
Via
Benzinga
Analyst Ratings for CytomX Therapeutics
July 07, 2022
Analysts have provided the following ratings for CytomX Therapeutics (NASDAQ:CTMX) within the last quarter:
Via
Benzinga
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
November 18, 2022
Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 17, 2022
Via
Benzinga
Mullen (MULN) Stock Pops 4% on ELMS Funding News
November 17, 2022
Mullen (MULN) stock is on the move Thursday following news of the EV company acquiring funding for its purchase of ELMS assets.
Via
InvestorPlace
Why Is CytomX Therapeutics (CTMX) Stock Up 29% Today?
November 17, 2022
CytomX Therapeutics (CTMX) stock is rising higher on Wednesday after announcing a partnership with Regeneron Pharmaceuticals (REGN).
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 17, 2022
Via
Benzinga
Heska To $165? Plus BTIG Cuts PT On This Stock By 67%
November 14, 2022
BTIG cut the price target on Gain Therapeutics, Inc. (NASDAQ: GANX) from $30 to $10. BTIG analyst Thomas Shrader maintained a Buy rating on the stock. Gain Therapeutics shares rose 1.3% to close at...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
November 10, 2022
Upgrades
Via
Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
September 07, 2022
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.
Via
Benzinga
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session
September 06, 2022
Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
September 06, 2022
Good morning, trader! It's time to start off the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!
Via
InvestorPlace
Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket
September 06, 2022
Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday.
Via
Benzinga
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
July 14, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Nasdaq Surges 250 Points; Crude Oil Rises Sharply
July 07, 2022
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping 250 points following the release of data on initial jobless claims.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2022
July 11, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 07, 2022
Via
Benzinga
This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday
July 08, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
July 07, 2022
Thursday's session saw 49 companies set new 52-week lows.
Via
Benzinga
Dow Jumps More Than 200 Points; Samsung Sees This Much Surge In Quarterly Revenue
July 07, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones jumping more than 200 points following the release of data on initial jobless claims.
Via
Benzinga
What To Know About Mizuho's Downgrade of CytomX Therapeutics
July 07, 2022
Mizuho downgraded its rating of CytomX Therapeutics (NASDAQ:CTMX) to Neutral with a price target of $4.00, changing its price target from $16.00 to $4.00. Shares of CytomX Therapeutics are trading down...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.